Assignee
CureVac SE
DE·62 granted patents·56 pending applications·182 citations·filing 2016–2025
Top patents by PatentIndex Score
118 records- 0198US11965000B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·7 cites·30 claims
- 0298US11739125B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2021·Granted Aug 29, 2023·10 cites·15 claims
- 0397US11761009B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2022·Granted Sep 19, 2023·5 cites·60 claims
- 0497US11596686B2Coronavirus vaccineCureVac SE·Filed 2022·Granted Mar 7, 2023·16 cites·30 claims
- 0597US11576966B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Feb 14, 2023·16 cites·27 claims
- 0696US12318486B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Jun 3, 2025·3 cites·16 claims
- 0796US12138348B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Nov 12, 2024·3 cites·20 claims
- 0896US11786590B2Rotavirus vaccinesCureVac SE·Filed 2022·Granted Oct 17, 2023·5 cites·16 claims
- 0995US12442005B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2023·Granted Oct 14, 2025·1 cites·41 claims
- 1095US11964012B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·2 cites·29 claims
- 1195US11596699B2RNA encoding an antibodyCureVac SE·Filed 2017·Granted Mar 7, 2023·11 cites·19 claims
- 1295US11559570B2Prime-boost regimens involving administration of at least one mRNA constructCureVac SE·Filed 2016·Granted Jan 24, 2023·8 cites·22 claims
- 1394US12318444B2Rotavirus vaccinesCureVac SE·Filed 2023·Granted Jun 3, 2025·1 cites·20 claims
- 1494US12168050B2Compositions comprising a norovirus nucleic acid and methods of use thereofCureVac SE·Filed 2021·Granted Dec 17, 2024·4 cites·28 claims
- 1594US11602557B2Bunyavirales vaccineCureVac SE·Filed 2018·Granted Mar 14, 2023·11 cites·20 claims
- 1693US11690910B2Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCureVac SE·Filed 2019·Granted Jul 4, 2023·6 cites·20 claims
- 1792US12240873B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Mar 4, 2025·0 cites·46 claims
- 1892US11918643B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2021·Granted Mar 5, 2024·6 cites·27 claims
- 1992US11524066B2Henipavirus vaccineCureVac SE·Filed 2017·Granted Dec 13, 2022·8 cites·19 claims
- 2092US2025129128A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2024·Application pending·0 cites
- 2192US2025352636A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCureVac SE·Filed 2024·Application pending·0 cites
- 2291US12161711B2Lassa virus vaccineCureVac SE·Filed 2022·Granted Dec 10, 2024·1 cites·14 claims
- 2391US12139513B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Nov 12, 2024·0 cites·44 claims
- 2491US12097253B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Sep 24, 2024·1 cites·45 claims
- 2591US11872280B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2022·Granted Jan 16, 2024·5 cites·24 claims
- 2691US11692002B2RNA sequence adaptationCureVac SE·Filed 2018·Granted Jul 4, 2023·7 cites·22 claims
- 2791US11525158B2Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNACureVac SE·Filed 2018·Granted Dec 13, 2022·8 cites·19 claims
- 2891US2026028627A1Artificial nucleic acid molecules for improved protein or peptide expressionCureVac SE·Filed 2025·Application pending·0 cites
- 2991US2025345411A1Vaccination in newborns and infantsCureVac SE·Filed 2025·Application pending·0 cites
- 3091US2026091107A1Coronavirus vaccineCureVac SE·Filed 2025·Application pending·0 cites
- 3190US12036277B2Vaccination with mRNA-coded antigensCureVac SE·Filed 2024·Granted Jul 16, 2024·0 cites·24 claims
- 3290US11697816B2Artificial nucleic acid moleculesCureVac SE·Filed 2016·Granted Jul 11, 2023·5 cites·22 claims
- 3390US11608513B2Method for adding cap structures to RNA using immobilized enzymesCureVac SE·Filed 2016·Granted Mar 21, 2023·7 cites·15 claims
- 3489US11739335B2Nucleic acids encoding CRISPR-associated proteins and uses thereofCureVac SE·Filed 2018·Granted Aug 29, 2023·7 cites·18 claims
- 3589US2024390478A1Vaccination in elderly patientsCureVac SE·Filed 2024·Application pending·0 cites
- 3688US12390520B2Vaccination in newborns and infantsCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·47 claims
- 3788US12194089B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Jan 14, 2025·1 cites·52 claims
- 3888US2023382954A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2023·Application pending·0 cites
- 3988US2026071224A1Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2025·Application pending·0 cites
- 4087US12460204B2Artificial nucleic acid molecules for improved protein or peptide expressionCureVac SE·Filed 2020·Granted Nov 4, 2025·1 cites·33 claims
- 4187US12390523B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·119 claims
- 4287US11542490B2RNAs for wound healingCureVac SE·Filed 2017·Granted Jan 3, 2023·8 cites·20 claims
- 4387US2025152745A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2024·Application pending·0 cites
- 4487US2025114307A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 4586US12527856B2Artificial RNA molecules encoding a norovirus antigen and uses thereofCureVac SE·Filed 2024·Granted Jan 20, 2026·0 cites·86 claims
- 4686US12109275B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2020·Granted Oct 8, 2024·1 cites·19 claims
- 4786US11964011B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·0 cites·39 claims
- 4886US11723967B2Zika virus vaccineCureVac SE·Filed 2017·Granted Aug 15, 2023·7 cites·15 claims
- 4986US2025302932A1Combination of vaccination and ox40 agonistsCureVac SE·Filed 2024·Application pending·0 cites
- 5086US2026090989A1LIPID NANOPARTICLE mRNA VACCINESCureVac SE·Filed 2025·Application pending·0 cites
Showing the top 50 of 118 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CureVac SE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →